OACCW
Oaktree Acquisition Corp. III Life Sciences WarrantKey Statistics
About Oaktree Acquisition Corp. III Life Sciences Warrant
Oaktree Acquisition Corp. III Life Sciences Warrant (OACCW) represents a strategic investment vehicle designed to capitalize on emerging opportunities within the life sciences sector. Sponsored by Oaktree Capital Management, a leader in alternative asset management, the SPAC aims to identify and drive growth in innovative healthcare companies. Institutional investors can leverage this warrant to access dynamic market trends, supported by Oaktree's extensive network and deep industry expertise, positioning OACCW as an attractive option for those seeking to participate in the evolving life sciences landscape.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.38% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.29 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -16.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $18.46M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
Volatility is currently expanding
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on OACCW and any ticker you trade — then tracks every position and per-strategy win rate.